Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60yr of age

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Patel, Samir J ^a   Knight, Richard J ^a   Suki, Wadi N ^b   Abdellatif, Abdul ^c   Duhart Jr , Benjamin T ^d   Krauss, Amy G ^d   Mannan, Saurabh ^a   Nezakatgoo, Nosratollah ^d   Osama Gaber, A ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b Kidney Institute   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d METHODIST UNIVERSITY HOSPITAL   (United States)

Author keywords

Antibody induction; Elderly; Kidney transplantation; Rabbit antithymocyte globulin

Indexed keywords

CALCINEURIN INHIBITOR; CLOTRIMAZOLE; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CADAVER KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MEDICAL RECORD REVIEW; ORGAN DONOR; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANIMALS; ANTILYMPHOCYTE SERUM; CADAVER; CREATININE; DELAYED GRAFT FUNCTION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RABBITS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS; YOUNG ADULT;

EID: 79958747834     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01393.x     Document Type: Article

References (16)

1. McCullough KP, Keith DS, Meyer KH, Stock PG, Brayman KL, Leichtman AB. Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Am J Transplant 2009: 9: 894.
2. Johnson DW, Herzig K, Purdie D et al. A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients. Transplantation 2000: 69: 794.
3. Savoye E, Tamarelle D, Chalem Y, Rebibou JM, Tuppin P. Survival benefits of kidney transplantation with expanded criteria deceased donors in patients aged 60years and over. Transplantation 2007: 84: 1618.
4. Moore PS, Farney AC, Hartmann EL et al. Experience with deceased donor kidney transplantation in 114 patients over age 60. Surgery 2007: 142: 514.
5. Fabrizii V, Winkelmayer WC, Klauser R et al. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol 2004: 15: 1052.
6. Pedroso S, Martins L, Fonseca I et al. Renal transplantation in patients over 60years of age: a single-center experience. Transplant Proc 2006: 38: 1885.
7. Foley DP, Patton PR, Meier-Kriesche HU et al. Long-term outcomes of kidney transplantation in recipients 60years of age and older at the University of Florida. Clin Transpl 2005: 101.
8. Nunes P, Mota A, Parada B et al. Do elderly patients deserve a kidney graft? Transplant Proc 2005: 37: 2737.
9. Heifets M, Saeed MI, Parikh MH, Sierka D, Kumar MS. Induction immunosuppression in kidney transplant recipients older than 60years of age: safety and efficacy of ATGAM, OKT3 and Simulect. Drugs Aging 2004: 21: 747.
10. Brennan DC, Flavin K, Lowell JA et al. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999: 67: 1011.
11. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 2006; 355:1967.
12. Patel SJ, Duhart BT, Krauss AG et al. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction. Transplantation 2008: 86: 313.
13. Gurk-Turner C, Airee R, Philosophe B, Kukuruga D, Drachenberg C, Haririan A. Thymoglobulin dose optimization for induction therapy in high risk kidney transplant recipients. Transplantation 2008: 85: 1425.
14. Klem P, Cooper JE, Weisss AS et al. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients. Transplantation 2009: 88: 891.
15. Meier-Kriesche HU, Kaplan B. Immunosuppression in the elderly renal transplant recipients. Are current regimens too aggressive? Drugs Aging 2001: 18: 751.
16. Meier-Kriesche HU, Srinivas TR, Kaplan B. Interaction between acute rejection and recipient age on long-term renal allograft survival. Transplant Proc 2001: 33: 3425.